Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Similar articles for PubMed (Select 22936443)

1.

Hypoxia-induced factor-1α in endometrial carcinoma: a mini-review of current evidence.

Dousias V, Vrekoussis T, Navrozoglou I, Paschopoulos M, Stefos T, Makrigiannakis A, Jeschke U.

Histol Histopathol. 2012 Oct;27(10):1247-53. Review.

PMID:
22936443
2.

Hypoxia-inducible factor 1 alpha is essential for hypoxic p27 induction in endometrioid endometrial carcinoma.

Horrée N, Gort EH, van der Groep P, Heintz AP, Vooijs M, van Diest PJ.

J Pathol. 2008 Jan;214(1):38-45.

PMID:
17985331
3.

Hypoxia contributes to development of recurrent endometrial carcinoma.

Pijnenborg JM, Wijnakker M, Hagelstein J, Delvoux B, Groothuis PG.

Int J Gynecol Cancer. 2007 Jul-Aug;17(4):897-904. Epub 2007 Mar 13.

PMID:
17359291
4.

Nuclear factor-κB2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1α independent manner.

Yeramian A, Santacana M, Sorolla A, Llobet D, Encinas M, Velasco A, Bahi N, Eritja N, Domingo M, Oliva E, Dolcet X, Matias-Guiu X.

Lab Invest. 2011 Jun;91(6):859-71. doi: 10.1038/labinvest.2011.58. Epub 2011 May 2.

5.

Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.

Sivridis E, Giatromanolaki A, Gatter KC, Harris AL, Koukourakis MI; Tumor and Angiogenesis Research Group.

Cancer. 2002 Sep 1;95(5):1055-63.

6.

Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.

Seeber LM, Horrée N, van der Groep P, van der Wall E, Verheijen RH, van Diest PJ.

BMC Cancer. 2010 Jun 19;10:307. doi: 10.1186/1471-2407-10-307.

7.

Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas.

Ozbudak IH, Karaveli S, Simsek T, Erdogan G, Pestereli E.

Gynecol Oncol. 2008 Mar;108(3):603-8. doi: 10.1016/j.ygyno.2007.11.028. Epub 2008 Jan 11.

PMID:
18191183
8.

Increased expression of hypoxia-inducible factor 1alpha in type I and type II endometrial carcinomas.

Pansare V, Munkarah AR, Schimp V, Haitham Arabi M, Saed GM, Morris RT, Ali-Fehmi R.

Mod Pathol. 2007 Jan;20(1):35-43. Epub 2006 Nov 10.

9.

Expression of leptin, leptin receptor, and hypoxia-inducible factor 1 alpha in human endometrial cancer.

Koda M, Sulkowska M, Wincewicz A, Kanczuga-Koda L, Musiatowicz B, Szymanska M, Sulkowski S.

Ann N Y Acad Sci. 2007 Jan;1095:90-8.

PMID:
17404022
10.

BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1alpha pathway and prognosis.

Giatromanolaki A, Koukourakis MI, Gatter KC, Harris AL, Sivridis E.

J Clin Pathol. 2008 Feb;61(2):217-20. Epub 2007 May 18.

PMID:
17513511
11.

Plausible linkage of hypoxia-inducible factor (HIF) in uterine endometrial cancers.

Fujimoto J, Sato E, Alam SM, Jahan I, Toyoki H, Hong BL, Sakaguchi H, Tamaya T.

Oncology. 2006;71(1-2):95-101. Epub 2007 Mar 6.

PMID:
17341889
12.

Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.

Osada R, Horiuchi A, Kikuchi N, Yoshida J, Hayashi A, Ota M, Katsuyama Y, Melillo G, Konishi I.

Hum Pathol. 2007 Sep;38(9):1310-20. Epub 2007 Jun 6. Erratum in: Hum Pathol. 2008 Jan;39(1):147. Mellilo, Giovanni [corrected to Melillo, Giovanni].

PMID:
17555795
13.

Differential regulation of DEC2 among hypoxia-inducible genes in endometrial carcinomas.

Yunokawa M, Tanimoto K, Nakamura H, Nagai N, Kudo Y, Kawamoto T, Kato Y, Hiyama E, Hiyama K, Nishiyama M.

Oncol Rep. 2007 Apr;17(4):871-8.

PMID:
17342330
14.

Hypoxic stress simultaneously stimulates vascular endothelial growth factor via hypoxia-inducible factor-1α and inhibits stromal cell-derived factor-1 in human endometrial stromal cells.

Tsuzuki T, Okada H, Cho H, Tsuji S, Nishigaki A, Yasuda K, Kanzaki H.

Hum Reprod. 2012 Feb;27(2):523-30. doi: 10.1093/humrep/der405. Epub 2011 Nov 28.

15.

Prognostic significance of erythropoietin expression in human endometrial carcinoma.

Acs G, Xu X, Chu C, Acs P, Verma A.

Cancer. 2004 Jun 1;100(11):2376-86.

16.

Comparison of STAT3 with HIF-1alpha, Ob and ObR expressions in human endometrioid adenocarcinomas.

Wincewicz A, Koda M, Sulkowska M, Kanczuga-Koda L, Sulkowski S.

Tissue Cell. 2008 Dec;40(6):405-10. doi: 10.1016/j.tice.2008.04.004. Epub 2008 Jun 25.

PMID:
18579174
17.

Upregulation of hypoxia-inducible factor-1alpha mRNA and its clinical significance in non-small cell lung cancer.

Yohena T, Yoshino I, Takenaka T, Kameyama T, Ohba T, Kuniyoshi Y, Maehara Y.

J Thorac Oncol. 2009 Mar;4(3):284-90. doi: 10.1097/JTO.0b013e31819852d5.

PMID:
19190516
18.

[Mechanism of hypoxia inducing factor-1α in low endometrial receptivity].

Xu BF, Sun XX, Feng Y, Zhang AJ, Cheng LN.

Zhonghua Fu Chan Ke Za Zhi. 2011 May;46(5):355-9. Chinese.

PMID:
21733372
19.

Is the hypoxia-inducible factor pathway important in gastric cancer?

Griffiths EA, Pritchard SA, Welch IM, Price PM, West CM.

Eur J Cancer. 2005 Dec;41(18):2792-805. Epub 2005 Nov 14. Review.

PMID:
16290133
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk